References

Agency for Healthcare Research and Quality. Impact of Cancer-Related Decision Aids. Publication No. 02-E004 2002. Available at: http://www.ahrq.gov/clinic/epcsums/caaidsum.htm. Accessed May 4, 2004.

Alberg AJ, Selhub J, Shah KV, Viscidi RP, Comstock GW, Helzlsouer KJ. The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. Cancer Epidemiol Biomarkers Prev. 2000;9:761-764.

Alexander C, Cason Z, Benghuzzi H, Martin L. Cytohistological correlation of abnormal cervical lesions in Native American females in Mississippi. Biomed Sci Instrum. 2001;37:25-30.

Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85:840-842.

Aral SO, Soskoline V, Joesoef RM, O'Reilly KR. Sex partner recruitment as risk factor for STD: clustering of risky modes. Sex Transm Dis. 1991;18:10-17.

Austin RM, Baron PL, Gates CE. Opportunities for enhanced cervical and breast screening referral in Charleston County. J S C Med Assoc. 1993;89:323-328.

Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst. 1978;60:1209.

Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg C. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.

Becker TM, Wheeler CM, Key CR, Samet JM. Cervical cancer incidence and mortality in New Mexico's Hispanics, American Indians, and non-Hispanic whites. West J Med. 1992;156:376-379.

Bindman AB, Grumbach K, Osmond D, Vranizan K, Stewart AL. Primary care and receipt of preventive services. J Gen Intern Med. 1996;11:269-276.

Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ. 1999;48:1-22.

Bloom JR, Stewart SL, Koo J, Hiatt RA. Cancer screening in public health clinics: the importance of clinic utilization. Med Care. 2001;39:1345-1351.

Boyce JG, Fruchter RG, Romanzi L, Sillman FH, Maiman M. The fallacy of the screening interval for cervical smears. Obstet Gynecol. 1990;76:627-632.

Branoff R, Santi K, Campbell JK, Roetzheim R, Oler M. A family practice residency cervical screening project: perceived screening barriers. Fam Med. 1997;29:119-123.

Breast & cervical cancer report from ADH. J Ark Med Soc. 1998;94:346-347.

Breast and cervical cancer screening among underserved women. Baseline survey results from six states. The National Cancer Institute Cancer Screening Consortium for Underserved Women. Arch Fam Med. 1995;4:617-624.

Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93:1704-1713.

Breen N, Figueroa JB. Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: a prevention policy perspective. Am J Prev Med. 1996;12:319-326.

Brinton LA, Fraumeni JF Jr. Epidemiology of uterine cervical cancer. J Chronic Dis. 1986;39:1051-1065.

Brooks SE, Baquet CR, Gardner JF, Moses G, Ghosh A. Cervical cancer--the impact of clinical presentation, health and race on survival. J Assoc Acad Minor Phys. 2000;11:55-59.

Brown AD, Garber AM. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA. 1999;281:347-353.

Brown RK, Barker WH. Pap smear screening and invasive cervical cancer. J Fam Pract. 1982;15:875-879.

Buller D, Modiano MR, Guernsey de Zapien J, Meister J, Saltzman S, Hunsaker F. Predictors of cervical cancer screening in Mexican American women of reproductive age. J Health Care Poor Underserved. 1998;9:76-94.

Butterworth CE Jr, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. JAMA. 1992;267:528-533.

Calle EE, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and Pap smear screening in U.S. women. Am J Public Health. 1993;83:53-60.

Campbell MK, Tessaro I, DeVellis B, et al. Tailoring and targeting a worksite health promotion program to address multiple health behaviors among blue-collar women. Am J Health Promot. 2000;14:306-313.

Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37:583-587.

Cartwright PS, Dao AH, Reed GW. Human papillomavirus in women. A three-year experience in a county hospital colposcopy clinic. J Reprod Med. 1992;37:167-169.

Casey MM, Call KT, Klingner JM. Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med. 2001;21:182-188.

Castellano PZ, Wenger NK, Graves WL. Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for HERS. J Womens Health Gend Based Med. 2001;10:451-461.

Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. Cervical cancer screening practices among older women: results from the Maryland cervical cancer case-control study. J Clin Epidemiol. 1988;41:531-541.

Cerqueira EM, Santoro CL, Donozo NF, et al. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol. 1998;42:639-649.

Chao A, Becker TM, Jordan SW, Darling R, Gilliland FD, Key CR. Decreasing rates of cervical cancer among American Indians and Hispanics in New Mexico (United States). Cancer Causes Control. 1996;7:205-213.

Chavez LR, Hubbell FA, Mishra SI, Valdez RB. The influence of fatalism on self-reported use of Papanicolaou smears. Am J Prev Med. 1997;13:418-424.

Chen F, Trapido EJ, Davis K. Differences in stage at presentation of breast and gynecologic cancers among whites, blacks, and Hispanics. Cancer. 1994;73:2838-2842.

Chow WH, Greenberg RS, Liff JM. Decline in the incidence of carcinoma in situ of the cervix. Am J Public Health. 1986;76:1322-1324.

Christopherson WM, Scott MA. Trends in mortality from uterine cancer in relation to mass screening. Acta Cytol. 1977;21:5-9.

Christopherson WM, Lundin FE, Mendez WM, Parker JE. Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period. Cancer. 1976;38:1357-1366.

Coker AL, Jenkins GR, Busnardo MS, Chambers JC, Levine LZ, Pirisi L. Human papillomaviruses and cervical neoplasia in South Carolina. Cancer Epidemiol Biomarkers Prev. 1993;2:207-212.

Coker AL, Rosenberg AJ, McCann MF, Hulka BS. Active and passive cigarette smoke exposure and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1992;1:349-356.

Coughlin SS, Thompson TD, Hall HI, Logan P, Uhler RJ. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998 - 1999. Cancer. 2002;94:2801-2812.

Coughlin SS. Implementing breast and cervical cancer prevention programs among the Houma Indians of southern Louisiana: cultural and ethical considerations. J Health Care Poor Underserved. 1998;9:30-41.

Curtis P, Mintzer M, Morrell D, Resnick JC, Hendrix S, Qaqish BF. Characteristics and quality of Papanicolaou smears obtained by primary care clinicians using a single commercial laboratory. Arch Fam Med. 1999;8:407-413.

Curtis P, Morrell D, Hendrix S, Mintzer M, Resnick JC, Qaqish BF. Recall and treatment decisions of primary care providers in response to Pap smear reports. Am J Prev Med. 1997;13:427-431.

Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]. Lancet. 1992;339:959-960.

Davey-Sullivan BJ, Gearhart JG. The use of the Pap smear in Mississippi. J Miss State Med Assoc. 1991;32:167-171.

del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A1 and 1A2 cervical cancer: a SEER database study. Gynecol Oncol. 1999;75:113-117.

Desch CE, Grasso MA, McCue MJ, et al. A rural cancer outreach program lowers patient care costs and benefits both the rural hospitals and sponsoring academic medical center. J Rural Health. 1999;15:157-167.

DesHarnais S. The National Cancer Database: Review of Issues Related to Access to Care and Treatment Patterns. Reducing Health Disparities in High Cervical Cancer Mortality Regions Meeting. Corpus Christi, TX; November 29, 2001.

Devesa SS, Grauman DG, Blot WJ, Pennello G, Hoover RN, Fraumeni JF Jr. Atlas of Cancer Mortality in the United States, 1950-94. Washington, DC: U.S. Government Printing Office; 1999.

Devesa SS. Descriptive epidemiology of cancer of the uterine cervix. Obstet Gynecol. 1984;63:605-612.

Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286-1291.

Dietrich AJ, Tobin JN, Sox CH, et al. Cancer early-detection services in community health centers for the underserved. A randomized controlled trial. Arch Fam Med. 1998;7:320-327.

Dignan M, Michielutte R, Blinson K, et al. Effectiveness of health education to increase screening for cervical cancer among eastern-band Cherokee Indian women in North Carolina. J Natl Cancer Inst. 1996;88:1670-1676.

Dignan M, Michielutte R, Wells HB, Bahnson J. The Forsyth County Cervical Cancer Prevention Project--I. Cervical cancer screening for black women. Health Educ Res. 1994;9:411-420.

Dignan M, Michielutte R, Sharp P, Bahnson J, Young L, Beal P. The role of focus groups in health education for cervical cancer among minority women. J Community Health. 1990;15:369-375.

Duelberg SI. Preventive health behavior among black and white women in urban and rural areas. Soc Sci Med. 1992;34:191-198.

Dunn JE Jr, Crocker DW, Rube IF, Erickson CC, Coleman SA. Cervical cancer occurrence in Memphis and Shelby County, Tennessee, during 25 years of its cervical cytology screening program. Am J Obstet Gynecol. 1984;150:861-864.

Dunn JE, Jr, Schweitzer V. The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974. Am J Obstet Gynecol. 1981;139:868-876.

Durbin M, DiClemente RJ, Siegel D, Krasnovsky F, Lazarus N, Camacho T. Factors associated with multiple sex partners among junior high school students. J Adolesc Health. 1993;14:202-207.

Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113:214-226.

Egbert N, Parrot R. Self-efficacy and rural women's performance of breast and cervical cancer detection practices. J Health Commun. 2001;6:219-233.

Elnicki DM, Morris DK, Shockcor WT. Patient-perceived barriers to preventive health care among indigent, rural Appalachian patients. Arch Intern Med. 1995;155:421-424.

Eluf-Neto J. Number of sexual partners and smoking behavior as risk factors for cervical dysplasia: comments on the evaluation of interaction. Int J Epidemiol. 1994;23:1101-1104.

Etzi S, Lane DS, Grimson R. The use of mammography vans by low-income women: the accuracy of self-reports. Am J Public Health. 1994;84:107-109.

Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141:680-689.

Fasal E, Simmons ME, Kampert JB. Factors associated with high and low risk of cervical neoplasia. J Natl Cancer Inst. 1981;66:631-636.

Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med. 2000;9:439-445.

Fiscella K, Franks P. The adequacy of Papanicolaou smears as performed by family physicians and obstetrician-gynecologists. J Fam Pract. 1999;48:294-298.

Fisher M, Rosenfeld WD, Burk RD. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr. 1991;119:821-825.

Fox P, Amsberger P, Zhang X. An examination of differential follow-up rates in cervical cancer screening. J Community Health. 1997;22:199-209.

Frank-Stromborg M, Wassner LJ, Nelson M, Chilton B, Wholeben BE. A study of rural Latino women seeking cancer-detection examinations. J Cancer Educ. 1998;13:231-241.

Friedell GH, Rubio A, Maretzki A, et al. Community cancer control in a rural, underserved population: the Appalachian Leadership Initiative on Cancer Project. J Health Care Poor Underserved. 2001;12:5-19.

Friedell GH, Ross FE, Tucker TC, et al. Cervical cancer in Kentucky. J Ky Med Assoc. 2000;98:398-405.

Friedell GH, Tucker TC, Ross FE. The impact of poverty and education on lung and cervical cancer in Appalachian Kentucky. J Registry Manage. 1999;26:125-127.

Friedell GH, Linville LH, Rubio A, Wagner WD, Tucker TC. What providers should know about community cancer control. Cancer Pract. 1997;5:367-374.

Friedell GH, Tucker TC, McManmon E, Moser M, Hernandez C, Nadel M. Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst. 1992;84:1030-1032.

Fruchter RG, Nayeri K, Remy JC, et al. Cervix and breast cancer incidence in immigrant Caribbean women. Am J Public Health. 1990;80:722-724.

Fruchter RG, Boyce J, Hunt M. Missed opportunities for early diagnosis of cancer of the cervix. Am J Public Health. 1980;70:418-420.

Gifford MS, Stone IK. Quality, access, and clinical issues in a nurse practitioner colposcopy outreach program. Nurse Pract. 1993;18:25-29, 33-36.

Gilbert TJ, Sugarman JR, Cobb N. Abnormal Papanicolaou smears and colposcopic follow-up among American Indian and Alaska Native women in the pacific northwest. J Am Board Fam Pract. 1995;8:183-188.

Gilliland FD, Mahler R, Hunt WC, Davis SM. Preventive health care among rural American Indians in New Mexico. Prev Med. 1999;28:194-202.

Gilliland FD, Hunt WC, Key CR. Trends in the survival of American Indian, Hispanic, and non-Hispanic White cancer patients in New Mexico and Arizona, 1969-1994. Cancer. 1998;82:1769-1783.

Gilliland FD, Mahler R, Davis SM. Non-ceremonial tobacco use among southwestern rural American Indians: the New Mexico American Indian Behavioural Risk Factor Survey. Tob Control. 1998;7:156-160.

Giuliano AR, Papenfuss M, Abrahamsen M, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev. 2001;10:1129-1136.

Glover DD, Gordon H, Moore G, Larsen B. Chlamydia trachomatis antigen prevalence among pregnant women in West Virginia. W V Med J. 1992;88:548-551.

Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA. 2001;285:3107-3115.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med. 1999;130:97-107.

Goldsmith DF, Sisneros GC. Cancer prevention strategies among California farmworkers: preliminary findings. J Rural Health. 1996;12:343-348.

Gonzales JJ, Ranney J, West J. Nurse-initiated health promotion prompting system in an internal medicine residents' clinic. South Med J. 1989;82:342-344.

Goodwin JS, Hunt WC, Samet JM. Determinants of cancer therapy in elderly patients. Cancer. 1993;72:594-601.

Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85:566-570.

Grady KE, Lemkau JP, McVay JM, Reisine ST. The importance of physician encouragement in breast cancer screening of older women. Prev Med. 1992;21:766-780.

Graham S, Rawls W, Swanson M, McCurtis J. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix. Am J Epidemiol. 1982;115:729-735.

Graham S, Priore RL, Schueller EF, Burnett W. Epidemiology of survival from cancer of the cervix. J Natl Cancer Inst. 1972;49:639-647.

Greenberg RS, Chow WH, Liff JM. Recent trends in the epidemiology of cervical neoplasia. Acta Cytol. 1989;33:463-470.

Greenberg RS, Stevens JA, Whitaker JP. Cancer incidence rates among blacks in urban and rural Georgia. Am J Public Health. 1985;75:683-684.

Greenlund KJ, Kiefe CI, Gidding SS, et al. Difference in cardiovascular disease risk factors in black and white young adults: comparisons among five communities of the CARDIA and the Bogalusa heart studies. Ann Epidemiol. 1998;8:22-30.

Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract. 1997;5:361-366.

Gulitz E, Bustillo-Hernandez M, Kent EB. Missed cancer screening opportunities among older women: a provider survey. Cancer Pract. 1998;6:325-332.

Gulitz E, Hernandez MB, Kent EB. Missed cancer screening opportunities among older women: a review. Cancer Pract. 1998;6:289-295.

Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women. Cancer Epidemiol Biomarkers Prev. 2002;11:137-142.

Hall HI, Rogers JD, Weir HK, Miller DS, Uhler RJ. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S.,1976-1996. Cancer. 2000;89:1593-1602.

Hampton JW, Friedell GH. Cancer surveillance. A problem for Native Americans and Appalachian populations. Cancer. 2001;91:242-246.

Harlan LC, Bernstein AB, Kessler LG. Cervical cancer screening: who is not screened and why? Am J Public Health. 1991;81:885-890.

Harper DM, Moncurn MM, Harper WH, Burke GC, Rasmussen CA, Mumford MC. The technical performance and clinical feasibility of telecolposcopy. J Fam Pract. 2000;49:623-627.

Harris JM, Jr. Papanicolaou smear recommendations, patient complaints, and patient satisfaction in managed-care medical organizations. Med Care. 1995;33:272-279.

Harris R, Leininger L. Preventive care in rural primary care practice. Cancer. 1993;72:1113-1118.

Hart LG, Salsberg E, Phillips DM, Lishner DM. Rural health care providers in the United States. J Rural Health. 2003;18:211-232.

Hartmann KE, Nanda K, Hall S, Myers E. Technologic advances for evaluation of cervical cytology: is newer better? Obstet Gynecol Surv. 2001;(56):765-774.

Hawkins R, Curtiss C. Cancer resources for providers in the rural community. Cancer Pract. 1997;5:383-386.

Hayward RA, Shapiro MF, Freeman HE, Corey CR. Who gets screened for cervical and breast cancer? Results from a new national survey. Arch Intern Med. 1988;148:1177-1181.

Herrero R. Epidemiology of cervical cancer. J Natl Cancer Inst Monogr. 1996;(21):1-6.

Herrero R, Potischman N, Brinton LA, et al. A case-control study of nutrient status and invasive cervical cancer. Am J Epidemiol. 1991;134:1335-1346.

Hewitt M, Devesa S, Breen N. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analysis of the 1995 National Survey of Family Growth. Am J Public Health. 2002;92:666-669.

Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 2001;33:190-203.

Hildesheim A, Hadjimichael O, Schwartz PE, et al. Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol. 1999;180:571-577.

Hildesheim A, Gravitt PE, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis. 1993;20:279-285.

Hinds MW, Skaggs JW, Hernandez C. Cervical cancer mortality trends in Kentucky, 1971-83. J Ky Med Assoc. 1985;83:186-192.

Hinds MW, Skaggs JW, Allen DT. Site-specific cancer mortality trends among Kentucky residents: comparison of 1971 to 1975 with 1976 to 1980. South Med J. 1984;77:431-435.

Hisada M, van den Berg BJ, Strickler HD, et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control. 2001;12:335-341.

Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer. 1998;78:281-285.

Hodge FS, Fredericks L, Kipnis P. Patient and smoking patterns in northern California American Indian Clinics. Urban and rural contrasts. Cancer. 1996;78:1623-1628.

Hodge FS, Cummings S, Fredericks L, Kipnis P, Williams M, Teehee K. Prevalence of smoking among adult American Indian clinic users in northern California. Prev Med. 1995;24:441-446.

Hoffman-Goetz L, Breen NL, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis. 1998;8:43-51.

Hogness CG, Engelstad LP, Linck LM, Schorr KA. Cervical cancer screening in an urban emergency department. Ann Emerg Med. 1992;21:933-939.

Holden DJ, Moore KS, Holliday JL. Health education for a breast and cervical cancer screening program: using the ecological model to assess local initiatives. Health Educ Res. 1998;13:293-299.

Holmquist ND. Revisiting the effect of the Pap test on cervical cancer. Am J Public Health. 2000;90:620-623.

Holmquist N. The delayed diagnosis of invasive carcinoma of the uterine cervix. J La State Med Soc. 1990;142:37-39.

Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ. A single-visit cervical carcinoma prevention program offered at an inner city church: a pilot project. Cancer. 1999;86:2659-2667.

Howe HL, Keller JE, Lehnherr M. Relation between population density and cancer incidence, Illinois, 1986-1990. Am J Epidemiol. 1993;138:29-36.

Howe HL, Bzduch H. A survey of Pap smear screening in upstate New York. N Y State J Med. 1986;86:291-296.

Howe SL, Delfino RJ, Taylor TH, Anton-Culver H. The risk of invasive cervical cancer among Hispanics: evidence for targeted preventive interventions. Prev Med. 1998;27:674-680.

Howell E, Chen Y-T, Moradi M, Concato J. Cervical cancer practice patterns and appropriateness of therapy. Obstet Gynecol. 2000;183:407-413.

Hueston WJ, Hubbard ET. Preventive services for rural and urban African American adults. Arch Fam Med. 2000;9:263-266.

Hysterectomy prevalence and death rates for cervical cancer--United States, 1965-1988. MMWR Morb Mortal Wkly Rep. 1992;41:17-20.

Ives DG, Lave JR, Traven ND, Schulz R, Kuller LH. Mammography and Pap smear use by older rural women. Public Health Rep. 1996;111:244-250.

Janerich DT, Hadjimichael O, Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995;85:791-794.

Jennings-Dozier K, Lawrence D. Sociodemographic predictors of adherence to annual cervical cancer screening in minority women. Cancer Nurs. 2000;23:350-356.

Jones WB, Shingleton HM, Russell AH, et al. Patterns of care for invasive cervical cancer. Results of a national survey of 1984 and 1990. Cancer. 1995;76:1934-1947.

Jubelirer SJ, Blanton MF, Blanton PD, et al. Assessment of knowledge, attitudes, and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996;11:230-232.

Kanetsky PA, Gammon MD, Mandelblatt J, et al. Cigarette smoking and cervical dysplasia among non-Hispanic black women. Cancer Detect Prev. 1998;22:109-119.

Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272:530-534.

Keener B, Jubelirer SJ, German RR, Haddy L. The West Virginia Cancer Registry: historical development and preliminary results. W V Med J. 1995;91:144-146.

Kiefe CI, McKay SV, Halevy A, Brody BA. Is cost a barrier to screening mammography for low-income women receiving Medicare benefits? A randomized trial. Arch Intern Med. 1994;154:1217-1224.

Kim K, Rigal RD, Patrick JR, et al. The changing trends of uterine cancer and cytology: a study of morbidity and mortality trends over a twenty year period. Cancer. 1978;42:2439-2449.

Kirkman-Liff B, Kronenfeld JJ. Access to cancer screening services for women. Am J Public Health. 1992;82:733-735.

Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 2000;82:1332-1338.

Kleinman JC, Kopstein A. Who is being screened for cervical cancer? Am J Public Health. 1981;71:73-76.

Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989;261:737-743.

Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human Papillomavirus type 16 vaccine. N Engl J Med. 2002;347:1645-1651.

Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3-8.

Kreuter MW, Strecher VJ. Do tailored behavior change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial. Health Educ Res. 1996;11:97-105.

Lane DS. Compliance with referrals from a cancer-screening project. J Fam Pract. 1983;17:811-817.

Lantz PM, Weigers ME, House JS. Education and income differentials in breast and cervical cancer screening. Policy implications for rural women. Med Care. 1997;35:219-236.

Lantz PM, Stencil D, Lippert MT, Jaros L, Eaker ED. Implementation issues and cost associated with a proven strategy for increasing breast and cervical cancer screening among low-income women. J Public Health Manag Pract. 1996;2:54-59.

Lengerich EJ, Conlisk EA, Pisano E, Harris L, Holliday J. A program to control breast and cervical cancer in North Carolina. N C Med J. 1998;59:110-114.

Lepine LA, Hillis SD, Marchbanks PA, et al. Hysterectomy surveillance--United States, 1980-1993. MMWR CDC Surveill Summ. 1997;46:1-15.

Lerman C, Hanjani P, Caputo C, Miller S, Engstrom N, Engstrom P. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol. 1992;10:330-333.

Lerman C, Caputo C, Brody D. Factors associated with inadequate cervical cancer screening among lower income primary care patients. J Am Board Fam Pract. 1990;3:151-156.

Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst. 1991;83:997-1003.

Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis: possible relationship to cancer screening. Cancer. 1991;67:1454-1459.

Makuc DM, Freid VM, Kleinman JC. National trends in the use of preventive health care by women. Am J Public Health. 1989;79:21-26.

Mamon JA, Shediac MC, Crosby CB, Sanders B, Matanoski GM, Celentano DD. Inner-city women at risk for cervical cancer: behavioral and utilization factors related to inadequate screening. Prev Med. 1990;19:363-376.

Mandelblatt JS, Lawrence WF, Gaffikin L, et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst. 2002;94:1469-1483.

Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002;287:2372-2381.

Mandelblatt JS, Gold K, O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med. 1999;28:418-425.

Mandelblatt J, Freeman H, Winczewski D, et al. The costs and effects of cervical cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem. Am J Public Health. 1997;87:1182-1189.

Mandelblatt J, Traxler M, Lakin P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Harlem Study Team. Am J Prev Med. 1993;9:133-138.

Mandelblatt J, Traxler M, Lakin P, Kanetsky P, Kao R. Mammography and Papanicolaou smear use by elderly poor black women. The Harlem Study Team. J Am Geriatr Soc. 1992;40:1001-1007.

Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health. 1991;81:646-649.

Mandelblatt JS, Fahs MC. The cost-effectiveness of cervical cancer screening for low-income elderly women. JAMA. 1988;259:2409-2413.

Manfredi C, Czaja R, Freels S, Trubitt M, Warnecke R, Lacey L. Prescribe for health: improving cancer screening in physician practices serving low-income and minority populations. Arch Fam Med. 1998;7:329-337.

Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 1992;30:216-230.

Marshall TA, Stumbo PJ, Warren JJ, Xie XJ. Inadequate nutrient intakes are common and are associated with low diet variety in rural, community-dwelling elderly. J Nutr. 2001;131:2192-2196.

Mayer JA, Slymen DJ, Drew JA, Wright BL, Elder JP, Williams SJ. Breast and cervical cancer screening in older women: the San Diego Medicare Prevention Health Project. Prev Med. 1992;21:395-404.

McAlister AL, Fernandez-Esquer ME, Ramirez AG, et al. Community level cancer control in a Texas barrio: Part II--Base-line and preliminary outcome findings. J Natl Cancer Inst Monogr. 1995;(18):123-126.

McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Med. 1999;8:129-134.

McPhee SJ, Bird JA, Davis T, Ha NT, Jenkins CN, Le B. Barriers to breast and cervical cancer screening among Vietnamese-American women. Am J Prev Med. 1997;13:205-213.

McPhee SJ, Stewart S, Brock KC, Bird JA, Jenkins CN, Pham CG. Factors associated with breast and cervical cancer screening practices in Vietnamese American women. Cancer Detect Prev. 1997;21:510-521.

Melnikow J, Kohatsu ND, Chan BK. Put prevention into practice: a controlled evaluation. Am J Public Health. 2000;90:1622-1625.

Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med. 1999;8:510-514.

Merrill RM, Merrill AV, Mayer LS. Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women. Ethn Dis. 2000;10:248-256.

Michielutte R, Dignan M, Bahnson J, Wells HB. The Forsyth County Cervical Cancer Prevention Project--II. Compliance with screening follow-up of abnormal cervical smears. Health Educ Res. 1994;9:421-432.

Michielutte R, Sharp PC, Dignan MB, Blinson K. Cultural issues in the development of cancer control programs for American Indian populations. J Health Care Poor Underserved. 1994;5:280-296.

Michielutte R, Diseker RA, Young LD, May WJ. Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med. 1985;14:248-258.

Miller BE, Flax SD, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer. 1993;72:1281-1285.

Miller KS, Yunger J, Single N, Kunz J. Prevalence of abnormal Pap smears in rural family practice. J Rural Health. 1996;12:33-38.

Mitchell JB, McCormack LA. Time trends in late-stage diagnosis of cervical cancer. Differences by race/ethnicity and income. Med Care. 1997;35:1220-1224.

Monroe AC, Ricketts TC, Savitz LA. Cancer in rural versus urban populations. J Rural Health. 1992;8:212-220.

Montz F, Farber FL, Bristow RE, Cornelison T. Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis. Obstet Gynecol. 2001;97:781-788.

Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res. 1990;28:507-513.

Moscovice IS. Rural hospitals: a literature synthesis and health services research agenda. Health Serv Res. 1989;23:892-930.

Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics. 1999;103:539-545.

Muldoon JT, Schootman M, Morton RF. Utilization of cancer early detection services among farm and rural nonfarm adults in Iowa. J Rural Health. 1996;12:321-331.

Munoz H, Bosch FX. HPV and cervical neoplasia: review of case-control and cohort studies. In: Munoz N, Bosch FX, Shah KV, Meheus A. eds. The Epidemiology of Cervical Cancer and Human Papillomavirus. Lyon: Oxford University Press; 1992:251-261.

Nagy S, Watts GF, Nagy MC. Coital status and perceptions about sexual abstinence refusal skills. J Adolesc Health. 2002;31:79-83.

Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.

Napoles-Springer A, Perez-Stable EJ, Washington E. Risk factors for invasive cervical cancer in Latino women. J Med Systems. 1996;20:277-293.

Nasca PC, Ellish N, Caputo TA, Saboda K, Metzger B. An epidemiologic study of Pap screening histories in women with invasive carcinomas of the uterine cervix. N Y State J Med. 1991;91:152-156.

Nasca PC, Burnett WS, Greenwald P, Brennan K, Wolfgang P, Carlton K. Population density as an indicator of urban-rural differences in cancer incidence, upstate New York, 1968-1972. Am J Epidemiol. 1980;112:362-375.

National Cancer Data Base (NCDB) Survival Reports. American College of Surgeons; 2001.

Navarro AM, Senn KL, McNicholas LJ, Kaplan RM, Roppe B, Campo MC. Por La Vida model intervention enhances use of cancer screening test among Latinas. Am J Prev Med. 1998;15:32-41.

Nelson DE, Bland S, Powell-Griner E, et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA. 2002;287:2659-2667.

Norman S, Talbott EO, Kuller LH, et al. The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer. Arch Intern Med. 1991;151:58-64.

Norman SA, Talbott EO, Kuller LH, Krampe BR, Stolley PD. Demographic, psychosocial, and medical correlates of Pap testing: a literature review. Am J Prev Med. 1991;7:219-226.

Norman SA, Weinberg GB, Powell RK, Marconi KM. Cervical cancer study using the cancer registry. Penn Med. 1989;92:42-46.

North Carolina Rural Health Research Program. National Rural Health Policy Atlas. Chapel Hill, NC; 1991.

Oleszkowicz KL, Kresch GM, Painter JT. Pap smear screening in family physicians' offices in a rural area with a high cervical cancer rate. Fam Med. 1994;26:648-650.

O'Malley AS, Kerner J, Johnson AE, Mandelblatt J. Acculturation and breast cancer screening among Hispanic women in New York City. Am J Public Health. 1999;89:219-227.

O'Malley AS, Mandelblatt J, Gold K, Cagney KA, Kerner J. Continuity of care and the use of breast and cervical cancer screening services in a multiethnic community. Arch Intern Med. 1997;157:1462-1470.

Omar H, Callahan P, Aggarwal S, Perkins K, Young K. Cervical pathology in West Virginia adolescents. W V Med J. 2000;96:408-409.

Ornstein SM, Garr DR, Jenkins RG, Rust PF, Zemp L, Arnon A. Compliance with five health promotion recommendations in a university-based family practice. J Fam Pract. 1989;29:163-168.

Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res. 1996;2:181-185.

Pardanani NS, Tischler LP, Brown WH, Feo ED. Carcinoma of cervix. Evaluation of treatment in community hospital. N Y State J Med. 1975;75:1018-1021.

Paskett ED, Tatum CM, D'Agostino R, et al. Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer Epidemiol Biomarkers Prev. 1999;8:453-459.

Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev. 1996;5:721-726.

Paskett ED, Carter WB, Chu J, White E. Compliance behavior in women with abnormal Pap smears: developing and testing a decision model. Med Care. 1990;28:643-656.

Pearson RJ, Simon K, Pollard C, Frey-McClung V. Increasing screenings for breast and cervical cancer in West Virginia. W V Med J. 1994;90:50-51.

Perez-Stable EJ, Otero-Sabogal R, Sabogal F, McPhee SJ, Hiatt RA. Self-reported use of cancer screening tests among Latinos and Anglos in a prepaid health plan. Arch Intern Med. 1994;154:1073-1081.

Perez-Stable EJ, Sabogal F, Otero-Sabogal R, Hiatt RA, McPhee SJ. Misconceptions about cancer among Latinos and Anglos. JAMA. 1992;268:3219-3223.

Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles county. J Natl Cancer Inst. 1986;77:1063-1077.

Polednak AP. Reported pap test use by Hispanic women in Connecticut and Long Island. Conn Med. 1996;60:3-8.

Porkas R, Hufnagel VG. Hysterectomies in the United States, 1965-84. Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, CDC, 1987. DHHS publication no. (PHS)87-1753. (Vital and Health Statistics; series 13, no. 92).

Potosky AL, Breen N, Graubard BI, Parsons E. The association between health care coverage and the use of cancer screening tests. Med Care. 1998;36:257-270.

Ramirez AG, Suarez L, Laufman L, Barroso C, Chalela P. Hispanic women's breast and cervical cancer knowledge, attitudes, and screening behaviors. Am J Health Promot. 2000;14:292-299.

Ramsbottom-Lucier M, Emmett K, Rich EC, Wilson JF. Hills, ridges, mountains, and roads: geographical factors and access to care in rural Kentucky. J Rural Health. 1996;12:386-394.

Rankow EJ, Tessaro I. Cervical cancer risk and Papanicolaou screening in a sample of lesbian and bisexual women. J Fam Pract. 1998;47:139-143.

Ratman S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev. 2000;9:945-951.

Reding DJ, Lappe KA, Krueger M, Kolehouse BL, Steniel D, Leer RA. Cancer screening and prevention in rural Wisconsin: the Greater Marshfield experience. Wis Med J. 1997;96:32-37.

Ries LAG, Kosary CL, Hankey BF, Edwards BK. SEER Cancer Statistic Review, 1973-1996. Bethesda, MD: National Cancer Institute; 1999.

Rimer BK, Conaway M, Lyna P, et al. The impact of tailored interventions on a community health center population. Patient Educ Couns. 1999;37:125-140.

Rimer BK, Conaway MR, Lyna PR, et al. Cancer screening practices among women in a community health center population. Am J Prev Med. 1996;12:351-357.

Risk for cervical disease in HIV-infected women--New York City. MMWR Morb Mortal Wkly Rep. 1990;39:846-849.

Robie PW. Improving and sustaining outpatient cancer screening by medicine residents. South Med J. 1988;81:902-905.

Rochat RW. The prevalence of cervical cancer screening in the United States in 1970. Am J Obstet Gynecol. 1976;125:478-483.

Rogot E, Sorlie PD, Johnson NJ, Schmitt C. A Mortality Study of 1.3 Million Persons by Demographic, Social, and Economic Factors: 1979-1985 Follow-up. U.S. National Longitudinal Mortality Study. Bethesda, MD: National Institutes of Health; 1992. NIH Pub. No. 92-3297.

Rosenfeld JA. The natural history of Pap test screening in a rural population. Tenn Med. 1998;91:179-182.

Rowland D, Lyons B. Triple jeopardy: rural, poor, and uninsured. Health Serv Res. 1989;23:975-1004.

Saikaly HH, Martin D, Traylor L. Evaluation of a cytologic cervical cancer screening program. J Ky Med Assoc. 1987;85:75-77.

Samet JM, Key CR, Hunt WC, Goodwin JS. Survival of American Indian and Hispanic cancer patients in New Mexico and Arizona, 1969-1982. J Natl Cancer Inst. 1987;79:457-463.

Saunders LD. Differences in the timeliness of diagnosis, breast and cervical cancer, San Francisco 1974-85. Am J Public Health. 1989;79:69-70.

Sawaya GF, Brown AD, Washington AE, Garber AM. Current approaches to cervical-cancer screening. N Engl J Med. 2001;344:1603-1607.

Sawaya GF, Sung HY, Kearney KA, et al. Advancing age and cervical cancer screening and prognosis. J Am Geriatr Soc. 2001;49:1499-1504.

Sawyer JA, Earp J, Fletcher R, Daye FF, Wynn TM. Pap tests of rural black women. J Gen Intern Med. 1990;5:115-119.

Sawyer JA, Earp JA, Fletcher RH, Daye FF, Wynn TM. Accuracy of women's self-report of their last Pap smear. Am J Public Health. 1989;79:1036-1037.

Schapira DV, Pamies RJ, Kumar NB, et al. Cancer screening: knowledge, recommendations, and practices of physicians. Cancer. 1993;71:839-843.

Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 1995;87:1345-1347.

Schiffman MH, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol. 1995;33:545-550.

Schiffman MH, Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. 1994;54:1944s-1947s.

Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 1992;84:394-398.

Schneider A, Zahm DM, Greinke C, Kirchmayr R, Nindl I. Different detectability of high-risk HPV in smears from incident and prevalent high-grade squamous intraepithelial lesions of the cervix. Gynecol Oncol. 1997;65:399-404.

Schootman M, Myers-Geadelmann J, Fuortes L. Factors associated with adequacy of diagnostic workup after abnormal breast cancer screening results. J Am Board Fam Pract. 2000;13:94-100.

Schootman M, Fuortes LJ. Breast and cervical carcinoma: the correlation of activity limitations and rurality with screening, disease incidence, and mortality. Cancer. 1999;86:1087-1094.

Schreiner DT, Petrusa ER, Rettie CS, Kluge RM. Improving compliance with preventive medicine procedures in a house staff training program. South Med J. 1988;81:1553-1557.

Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.

Shelton D, Paturzo D, Flannery J, Gregorio D. Race, stage of disease, and survival with cervical cancer. Ethn Dis. 1992;2:47-54.

Shepherd J, Peersman G, Weston R, Napuli I. Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women. Health Educ Res. 2000;15:681-694.

Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995;76:1948-1955.

Sigurdsson K, Arnadottir T, Snorradottir M, Benediktsdottir K, Saemundsson H. Human papillomavirus (HPV) in an Icelandic population: the role of HPV DNA testing based on hybrid capture and PCR assays among women with screen-detected abnormal Pap smears. Int J Cancer. 1997;72:446-452.

Skaer TL, Robison LM, Sclar DA, Harding GH. Cancer-screening determinants among Hispanic women using migrant health clinics. J Health Care Poor Underserved. 1996;7:338-354.

Skaer TL, Robison LM, Sclar DA, Harding GH. Knowledge, attitudes, and patterns of cancer screening: a self-report among foreign born Hispanic women utilizing rural migrant health clinics. J Rural Health. 1996;12:169-177.

Slattery ML, Abbott TM, Overall Jr JC, et al. Dietary vitamins A, C, and E selenium as risk factors for cervical cancer. Epidemiology. 1990;1:8-15.

Slattery ML, Overall JC Jr, Abbott TM, French TK, Robison LM, Gardner J. Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol. 1989;130:248-258.

Solis JM, Marks G, Garcia M, Shelton D. Acculturation, access to care, and use of preventive services by Hispanics: findings from HHANES 1982-84. Am J Public Health. 1990;80:11-19.

Sox CH, Dietrich AJ, Goldman DC, Provost EM. Improved access to women's health services for Alaska natives through community health aide training. J Community Health. 1999;24:313-323.

Spires SE. The Pap smear, an "endangered" species. J Ky Med Assoc. 1997;95:155-156.

Spitler HD, Mayo RM, Parker VG. Patterns of breast, cervical, colorectal, and prostate cancer in the Appalachian region of South Carolina. Ethn Dis. 2001;11:51-59.

Spurlock C, Nadel M, McManmon E. Age and Pap smear history as a basis for intervention strategy. J Community Health. 1992;17:97-107.

Stanhope CR, Smith JP, Wharton JT, Rutledge FN, Fletcher GH, Gallager HS. Carcinoma of the cervix: the effect of age on survival. Gynecol Oncol. 1980;10:188-193.

Stearns SC, Slifkin RT, Edin HM. Access to care for rural Medicare beneficiaries. J Rural Health. 2000;16:31-42.

Stern E, Misczynski M, Greenland S, Damus K, Coulson A. "Pap" testing and hysterectomy prevalence: a survey of communities with high and low cervical cancer rates. Am J Epidemiol. 1977;106:296-305.

Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002;136:641-651.

Strickland J, Strickland DL. Barriers to preventive health services for minority households in the rural South. J Rural Health. 1996;12:206-217.

Suarez L, Roche RA, Nichols D, Simpson DM. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women. Am J Prev Med. 1997;13:137-142.

Suarez L, Roche RA, Pulley L, Weiss NS, Goldman D, Simpson DM. Why a peer intervention program for Mexican-American women failed to modify the secular trend in cancer screening. Am J Prev Med. 1997;13:411-417.

Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med. 1995;11:94-98.

Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr. 1995;(18):41-47.

Suarez L. Pap smear and mammogram screening in Mexican-American women: the effects of acculturation. Am J Public Health. 1994;84:742-746.

Suarez L, Nichols DC, Brady CA. Use of peer role models to increase Pap smear and mammogram screening in Mexican-American and black women. Am J Prev Med. 1993;9:290-296.

Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000;88:2283-2289.

Sung JF, Blumenthal DS, Alema-Mensah E, McGrady GA. Racial and urban/rural differences in cervical carcinoma in Georgia Medicaid recipients. Cancer. 1997;80:231-236.

Tatum C, Wilson A, Dignan M, Paskett ED, Velez R. Development and implementation of outreach strategies for breast and cervical cancer prevention among African American women. FoCaS Project. Forsyth Country Cancer Screening. J Cancer Educ. 1997;12:43-50.

Thomas SM, Fick AC. Women's health: early detection and screening practices for breast and cervical cancer. J La State Med Soc. 1994;146:152-158.

Thoms WW, Unger ER, Carisio R, et al. Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital. J Natl Med Assoc. 1998;90:303-308.

Thoms WW, Unger ER, Johnson PR, et al. Cervical cancer survival in a high risk urban population. Cancer. 1995;76:2518-2523.

Traczyk JM, Johnson SG, Komaniecki TF, et al. CLIA's Impact on the Availability of Laboratory Services. Washington, DC: Office of Inspector General, U.S. Department of Health and Human Services; 1995. DHHS publication OEI-05-94-00130, i-C-4.

Trapido EJ, Valdez RB, Obeso JL, Strickman-Stein N, Rotger A, Perez-Stable EJ. Epidemiology of cancer among Hispanics in the United States. J Natl Cancer Inst Monogr. 1995;(18):17-28.

Trimble E. Exploring SEER Treatment Data. Reducing Health Disparities in High Cervical Cancer Mortality Regions Meeting. Corpus Christi, TX; November 28, 2001.

Tseng DS, Cox E, Plane MB, HLA KM. Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis. J Gen Intern Med. 2001;16:563-568.

Tucker TC, Friedell GH, Stallones L, Thompson JR, Bagby JW. Cancer Mortality in Rural Appalachian Kentucky. Appalachian Data Bank Report #6; 1988:1-16.

Turner RC, Waivers LE, O'Brien K. The effect of patient carried reminder cards on the performance of health maintenance measures. Arch Intern Med. 1990;150:645-647.

Ursin G, Pike MC, Preston-Martin S, d'Ablaing G, III, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control. 1996;7:391-401.

Ursin G, Peters RK, Henderson BE, d'Ablaing G, III, Monroe KR, Pike MC. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 1994;344:1390-1394.

U.S. Census Bureau. American Community Survey. Available at: http://www.census.gov/acs/www/. Accessed May 4, 2004.

U.S. Congress, Office of Technology Assessment. Health Care in Rural America, OTA-H-434. Washington, DC: U.S. Government Printing Office; 1990.

Vellozzi CJ, Romans M, Rothenberg RB. Delivering breast and cervical cancer screening services to underserved women: Part I. Literature review and telephone survey. Womens Health Issues. 1996;6:65-73.

Vernon SD, Unger ER, Piper MA, et al. HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners. Sex Transm Inf. 1999;75:258-260.

Vincent AL, Greene JN, Hoercherl S, McTague D. Women at risk: Papanicolaou smear screening in Florida. J Fla Med Assoc. 1997;84:302-307.

Vitolins MZ, Quandt SA, Case LD, Bell RA, Arcury TA, McDonald J. Vitamin and mineral supplement use by older rural adults. J Gerontol A Biol Sci Med Sci. 2000;55:M613-M617.

Walker R, Lucas W, Crespo R. The West Virginia Rural Cancer Prevention project. Cancer Pract. 1994;2:421-426.

Warnecke RB, Graham S. Characteristics of blacks obtaining Papanicolaou smears. Cancer. 1976;37:2015-2025.

Wassertheil-Smoller S, Romney SL, Wylie-Rosett J, et al. Dietary vitamin C and uterine cervical dysplasia. Am J Epidemiol. 1981;114:714-724.

Weinrich S, Coker Al, Weinrich M, Eleazer GP, Greene FL. Predictors of Pap smear screening in socioeconomically disadvantaged elderly women. J Am Geriatr Soc. 1995;43:267-270.

Weiss HL, Soong SJ, Partridge EE, Carpenter J, Bryant B, Waterbor JW. Cancer incidence among predominantly black, rural-poor populations in southern states. South Med J. 1997;90:986-992.

Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis. 2001;28:321-325.

Wilcox LS, Mosher WD. Factors associated with obtaining health screening among women of reproductive age. Public Health Rep. 1993;108:76-86.

Willems JP, Saunders JT, Hunt DE, Schorling JB. Prevalence of coronary heart disease risk factors among rural blacks: a community base study. South Med J. 1997;90:814-820.

Williams RB, Boles M, Johnson RE. A patient-initiated system for preventive health care: a randomized trial in community-based primary care practices. Arch Fam Med. 1998;7:338-345.

Windsor RA, Kronenfeld JJ, Cain MG, Cutter GR, Goodson LA, Edwards E. Increasing utilization of a rural cervical cancer detection program. Am J Public Health. 1981;71:641-643.

Wyatt SW, Lancaster M, Bottorff D, Ross F. History of tobacco use among Kentucky women diagnosed with invasive cervical cancer: 1997-1998. J Ky Med Assoc. 2001;99:537-539.

Yabroff KR, Mangan P, Mandelblatt JS. Effectiveness of interventions to increase Pap smear use. J Am Board Fam Pract. 2003;16:188-203.

Yabroff KR. American Hospital Association Data Review. Reducing Health Disparities in High Cervical Cancer Mortality Regions Meeting. Corpus Christi, TX; November 28, 2001.

Yobs AR, Plott AE, Hicklin MD, et al. Retrospective evaluation of gynecologic cytodiagnosis: II. Interlaboratory reproducibility as shown in rescreening large consecutive samples of reported cases. Acta Cytol. 1987;31:900-910.

Zhang P, Tao G, Irwin KL. Utilization of preventive medical services in the United States: a comparison between rural and urban populations. J Rural Health. 2000;16:349-356.